It has been established that in breast and pancreatic cancer ZEB1-driven EMT downregulates the expression of the RBP and splicing regulator ESRP1 as part of a self-enforcing feedback loop (Preca et al., 2015). This evidence concerns the gene ZEB1 and familial pancreatic carcinoma.